- call +1-201-465-4211
- email sales@mrinsights.biz
Mucormycosis is any fungal infection caused by fungi in the order Mucorales. Generally, species in the Mucor, Rhizopus, Absidia, and Cunninghamella genera are most often implicated. The disease is often characterized by hyphae growing in and around blood vessels and can be potentially life-threatening in diabetic or severely immunocompromised individuals.
Scope of the Report:
This report studies the Mucormycosis market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Mucormycosis market by product type and applications/end industries.
If mucormycosis is suspected, amphotericin B therapy should be immediately administered due to the rapid spread and high mortality rate of the disease. Amphotericin B is usually administered for an additional 4–6 weeks after initial therapy begins to ensure eradication of the infection. After administration of either amphotericin B or posaconazole, surgical removal of the "fungus ball" is indicated. The disease must be monitored carefully for any signs of reemergence.
The global Mucormycosis market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Mucormycosis.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
Market Segment by Companies, this report covers
Abbott Laboratories
Biocon
Cadila Pharmaceuticals
Novartis
Merck
Roche
Bristol Myers Squibb
Pfizer
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Rhizopus
Rhizomucor
Cunninghamella
Apophysomyces
Saksenaea
Lichtheimia (Absidia)
Mucor
Market Segment by Applications, can be divided into
Hospitals & Clinics
Medical Institutes
Research Organization
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Mucormycosis Market Overview
1.1 Product Overview and Scope of Mucormycosis
1.2 Classification of Mucormycosis by Types
1.2.1 Global Mucormycosis Revenue Comparison by Types (2017-2023)
1.2.2 Global Mucormycosis Revenue Market Share by Types in 2017
1.2.3 Rhizopus
1.2.4 Rhizomucor
1.2.5 Cunninghamella
1.2.6 Apophysomyces
1.2.7 Saksenaea
1.2.8 Lichtheimia (Absidia)
1.2.9 Mucor
1.3 Global Mucormycosis Market by Application
1.3.1 Global Mucormycosis Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Hospitals & Clinics
1.3.3 Medical Institutes
1.3.4 Research Organization
1.4 Global Mucormycosis Market by Regions
1.4.1 Global Mucormycosis Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Mucormycosis Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Mucormycosis Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Mucormycosis Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Mucormycosis Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Mucormycosis Status and Prospect (2013-2023)
1.5 Global Market Size of Mucormycosis (2013-2023)
2 Manufacturers Profiles
2.1 Abbott Laboratories
2.1.1 Business Overview
2.1.2 Mucormycosis Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Abbott Laboratories Mucormycosis Revenue, Gross Margin and Market Share (2016-2017)
2.2 Biocon
2.2.1 Business Overview
2.2.2 Mucormycosis Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Biocon Mucormycosis Revenue, Gross Margin and Market Share (2016-2017)
2.3 Cadila Pharmaceuticals
2.3.1 Business Overview
2.3.2 Mucormycosis Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Cadila Pharmaceuticals Mucormycosis Revenue, Gross Margin and Market Share (2016-2017)
2.4 Novartis
2.4.1 Business Overview
2.4.2 Mucormycosis Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Novartis Mucormycosis Revenue, Gross Margin and Market Share (2016-2017)
2.5 Merck
2.5.1 Business Overview
2.5.2 Mucormycosis Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Merck Mucormycosis Revenue, Gross Margin and Market Share (2016-2017)
2.6 Roche
2.6.1 Business Overview
2.6.2 Mucormycosis Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Roche Mucormycosis Revenue, Gross Margin and Market Share (2016-2017)
2.7 Bristol Myers Squibb
2.7.1 Business Overview
2.7.2 Mucormycosis Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Bristol Myers Squibb Mucormycosis Revenue, Gross Margin and Market Share (2016-2017)
2.8 Pfizer
2.8.1 Business Overview
2.8.2 Mucormycosis Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Pfizer Mucormycosis Revenue, Gross Margin and Market Share (2016-2017)
3 Global Mucormycosis Market Competition, by Players
3.1 Global Mucormycosis Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Mucormycosis Players Market Share
3.2.2 Top 10 Mucormycosis Players Market Share
3.3 Market Competition Trend
4 Global Mucormycosis Market Size by Regions
4.1 Global Mucormycosis Revenue and Market Share by Regions
4.2 North America Mucormycosis Revenue and Growth Rate (2013-2018)
4.3 Europe Mucormycosis Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Mucormycosis Revenue and Growth Rate (2013-2018)
4.5 South America Mucormycosis Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Mucormycosis Revenue and Growth Rate (2013-2018)
5 North America Mucormycosis Revenue by Countries
5.1 North America Mucormycosis Revenue by Countries (2013-2018)
5.2 USA Mucormycosis Revenue and Growth Rate (2013-2018)
5.3 Canada Mucormycosis Revenue and Growth Rate (2013-2018)
5.4 Mexico Mucormycosis Revenue and Growth Rate (2013-2018)
6 Europe Mucormycosis Revenue by Countries
6.1 Europe Mucormycosis Revenue by Countries (2013-2018)
6.2 Germany Mucormycosis Revenue and Growth Rate (2013-2018)
6.3 UK Mucormycosis Revenue and Growth Rate (2013-2018)
6.4 France Mucormycosis Revenue and Growth Rate (2013-2018)
6.5 Russia Mucormycosis Revenue and Growth Rate (2013-2018)
6.6 Italy Mucormycosis Revenue and Growth Rate (2013-2018)
7 Asia-Pacific Mucormycosis Revenue by Countries
7.1 Asia-Pacific Mucormycosis Revenue by Countries (2013-2018)
7.2 China Mucormycosis Revenue and Growth Rate (2013-2018)
7.3 Japan Mucormycosis Revenue and Growth Rate (2013-2018)
7.4 Korea Mucormycosis Revenue and Growth Rate (2013-2018)
7.5 India Mucormycosis Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Mucormycosis Revenue and Growth Rate (2013-2018)
8 South America Mucormycosis Revenue by Countries
8.1 South America Mucormycosis Revenue by Countries (2013-2018)
8.2 Brazil Mucormycosis Revenue and Growth Rate (2013-2018)
8.3 Argentina Mucormycosis Revenue and Growth Rate (2013-2018)
8.4 Colombia Mucormycosis Revenue and Growth Rate (2013-2018)
9 Middle East and Africa Revenue Mucormycosis by Countries
9.1 Middle East and Africa Mucormycosis Revenue by Countries (2013-2018)
9.2 Saudi Arabia Mucormycosis Revenue and Growth Rate (2013-2018)
9.3 UAE Mucormycosis Revenue and Growth Rate (2013-2018)
9.4 Egypt Mucormycosis Revenue and Growth Rate (2013-2018)
9.5 Nigeria Mucormycosis Revenue and Growth Rate (2013-2018)
9.6 South Africa Mucormycosis Revenue and Growth Rate (2013-2018)
10 Global Mucormycosis Market Segment by Type
10.1 Global Mucormycosis Revenue and Market Share by Type (2013-2018)
10.2 Global Mucormycosis Market Forecast by Type (2018-2023)
10.3 Rhizopus Revenue Growth Rate (2013-2023)
10.4 Rhizomucor Revenue Growth Rate (2013-2023)
10.5 Cunninghamella Revenue Growth Rate (2013-2023)
10.6 Apophysomyces Revenue Growth Rate (2013-2023)
10.7 Saksenaea Revenue Growth Rate (2013-2023)
10.8 Lichtheimia (Absidia) Revenue Growth Rate (2013-2023)
10.9 Mucor Revenue Growth Rate (2013-2023)
11 Global Mucormycosis Market Segment by Application
11.1 Global Mucormycosis Revenue Market Share by Application (2013-2018)
11.2 Mucormycosis Market Forecast by Application (2018-2023)
11.3 Hospitals & Clinics Revenue Growth (2013-2018)
11.4 Medical Institutes Revenue Growth (2013-2018)
11.5 Research Organization Revenue Growth (2013-2018)
12 Global Mucormycosis Market Size Forecast (2018-2023)
12.1 Global Mucormycosis Market Size Forecast (2018-2023)
12.2 Global Mucormycosis Market Forecast by Regions (2018-2023)
12.3 North America Mucormycosis Revenue Market Forecast (2018-2023)
12.4 Europe Mucormycosis Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Mucormycosis Revenue Market Forecast (2018-2023)
12.6 South America Mucormycosis Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Mucormycosis Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
List of Tables and Figures
Figure Mucormycosis Picture
Table Product Specifications of Mucormycosis
Table Global Mucormycosis and Revenue (Million USD) Market Split by Product Type
Figur
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
